Genitourinary Small-Cell Carcinoma: A Single-Institution Experience
Open Access
- 1 October 2013
- journal article
- Published by MDPI AG in Current Oncology
- Vol. 20 (5), 258-264
- https://doi.org/10.3747/co.20.1338
Abstract
Background: Small-cell carcinomas (sccs) of the genitourinary (gu) tract are rare systemic diseases, and there is no standard treatment strategy for patients with this malignancy. The objectives of the present study were to report the management and outcome of patients with scc of the gu tract treated at a tertiary-care institution from 1982 to 2009. Methods: In a chart review of all patients diagnosed with scc of the gu tract between 1982 and 2009, data on demographics, clinical and pathologic characteristics, treatment, and patient outcomes were collected. Results: The 58 patients identified had scc in the following primary sites: urinary bladder (n = 35), prostate (n = 17), and upper urinary tract (n = 6). In 38 patients (66%), the scc was of pure histology; in the remainder, histology was mixed. Overall, 28 patients had limited-stage disease; 24 had extensive-stage disease; and staging was unknown in 6 patients. Median survival for the entire cohort was 7.5 months, with extensive-stage disease being identified as a poor prognostic factor (survival was 22.0 months for limited-stage patients and 4.1 months for extensive-stage patients, p < 0.001). Based on site, prostate patients fared worst, with a median survival of only 5.1 months. Compared with best supportive care, treatment was associated with better outcomes (median survival: 12.3 months vs. 2.3 months, p < 0.0001). Conclusions: Small-cell cancer of the gu tract is an aggressive cancer, with a poor prognosis overall. Although there is no standard of care, patients should be treated using a multimodality approach analogous to that used in the treatment of small-cell lung cancer.Keywords
This publication has 41 references indexed in Scilit:
- Clinical and therapeutic aspects of extrapulmonary small cell carcinomaCancer Treatment Reviews, 2009
- Prophylactic Cranial Irradiation in Extensive Small-Cell Lung CancerNew England Journal of Medicine, 2007
- Small-cell carcinoma of the urinary bladder: 10-year experienceClinical Oncology, 2004
- Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrenceGynecologic Oncology, 2004
- A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysisLung Cancer, 2000
- STAT3 mediates IL-6-induced neuroendocrine differentiation in prostate cancer cellsThe Prostate, 2000
- Primary Advanced Gastric Small Cell CarcinomaAmerican Journal Of Gastroenterology, 1999
- GENITOURINARY SMALL CELL CARCINOMA: DETERMINATION OF CLINICAL AND THERAPEUTIC FACTORS ASSOCIATED WITH SURVIVALJournal of Urology, 1998
- Primary small cell carcinoma of the esophagus: a review of the literature with emphasis on therapy and prognosis.1997
- Extrapulmonary small cell carcinomaCancer, 1997